Phase 1 Systemic Scleroderma Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmRheumatoid Arthritis+11 more

National Cancer Institute (NCI)300 enrolled52 locationsNCT03816345

Recruiting

Phase 1

Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease

DermatomyositisSystemic SclerodermaAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis+2 more

Chongqing Precision Biotech Co., Ltd24 enrolled1 locationNCT06056921